Samik Pharm Co Ltd is a Korea-based company engaged in the manufacturing and sales of pharmaceuticals business. The Company is mainly engaged in the manufacture of drugs such as circulatory machinery treatments such as Cesar Plus tablets and Eravix tablets, diabetes treatments such as Griffin tablets and Gluemser tablets, digestive machinery treatments such as Samik Pharmotidine tablets and Rebacode tablets, and antipyretic anti-inflammatory drugs such as Tamitrasemi tablets and Seklfen tablets. In addition, the Company is also engaged in the manufacturing of drugs such as treating acute or recurrent vaginal candidiasis, treating children with motion sickness, and treating alopecia. The Company sells its products in domestic and overseas markets.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
26-06-17	6,470.00 ₩	-8.10%	1,397,141
26-06-17	7,040.00 ₩	+6.02%	3,714,058
26-06-16	6,640.00 ₩	-13.77%	5,169,879
26-06-15	7,700.00 ₩	+29.85%	504,828
26-06-12	5,930.00 ₩	+4.22%	59,951

End-of-day quote Korea S.E.

More quotes

Income Statement and Estimates

More financial data

End-of-day quote Korea S.E. Other stock markets 2026-06-18			5-day change	1st Jan Change
6,470.00 ^KRW	-8.10%		+11.55%	-53.69%

Market Cap	64.75B 42.14M 36.72M 33.85M 31.84M 59.56M 3.97B 59.98M 403M 156M 1.96B 158M 155M 6.78B	P/E 2024 *	-	P/E 2025	-140x
Enterprise Value	35.7B 23.23M 20.24M 18.66M 17.55M 32.84M 2.19B 33.07M 222M 86.23M 1.08B 87.21M 85.34M 3.74B	EV / Sales 2024 *	-	EV / Sales 2025	1.65x
Free-Float	36.99%	Yield 2024 *	-	Yield 2025	-

1 day	-8.10%
1 week	+11.55%
Current month	+2.54%
1 month	-15.97%
3 months	-45.95%
6 months	-56.28%
Current year	-53.69%

1 week	5,630	8,350
1 month	5,490	8,350
Current year	5,490	21,800
1 year	5,490	25,050
3 years	5,490	25,050
5 years	5,490	25,050
10 years	5,490	25,050

Manager	Title	Age	Since
Chung-Hwan Lee CEO	Chief Executive Officer	59	2011-05-31
Young-I Kwon CEO	Chief Executive Officer	64	2016-11-30
Kyung-Hee Kwak PRN	Corporate Officer/Principal	56	2018-07-31

Samik Pharmaceutical Company LTD. Stock

Stocks

A014950

KR7014950000

Pharmaceuticals

Valuation: Samik Pharmaceutical Company LTD.

Chart: Samik Pharmaceutical Company LTD.

Latest news : Samik Pharmaceutical Company LTD.

Quotes and Performance

Course Extremes

Managers and Directors: Samik Pharmaceutical Company LTD.

Other Pharmaceuticals

Financials

Company Profile

Quotes

Income Statement and Estimates

Director	Title	Age	Since
Won-Mo Ahn BRD	Director/Board Member	71	2024-02-29
Young-I Kwon CHM	Chairman	64	2016-11-30
Chung-Hwan Lee CHM	Chairman	59	2011-05-31

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAMIK PHARMACEUTICAL COMPANY LTD.	-8.10%	+11.55%	-	-	46.52M
ELI LILLY AND COMPANY	-1.19%	-5.72%	+39.42%	+142.17%	992B
JOHNSON & JOHNSON	-2.55%	-4.44%	+51.09%	+38.76%	564B
ABBVIE INC.	-2.13%	-3.84%	+16.52%	+56.83%	391B
ROCHE HOLDING AG	-2.90%	+0.68%	+24.66%	+16.53%	330B
ASTRAZENECA PLC	-2.36%	-3.12%	+24.71%	+12.95%	280B
NOVARTIS AG	-2.45%	-2.88%	+24.29%	+29.93%	279B
NOVO NORDISK A/S	-1.91%	-0.87%	-41.95%	-48.26%	196B
AMGEN INC.	-1.66%	-5.10%	+16.01%	+46.99%	184B
GILEAD SCIENCES, INC.	-2.07%	-2.60%	+13.52%	+57.77%	156B
Average	-2.81%	+1.28%	+18.70%	+39.29%	337.13B
Weighted average by Cap.	-2.05%	-0.49%	+27.59%	+62.49%

	2024	2025
Net sales	55.86B 36.36M 31.68M 29.2M 27.47M 51.38M 3.43B 51.75M 347M 135M 1.69B 136M 134M 5.85B	60.02B 39.07M 34.04M 31.38M 29.51M 55.21M 3.68B 55.6M 373M 145M 1.81B 147M 143M 6.29B
Net income	3.52B 2.29M 2M 1.84M 1.73M 3.24M 216M 3.26M 21.91M 8.51M 106M 8.6M 8.42M 369M	-755M -491K -428K -395K -371K -694K -46.31M -699K -4.7M -1.82M -22.82M -1.84M -1.8M -79.1M
Net Debt	-12.84B -8.36M -7.28M -6.71M -6.31M -11.81M -788M -11.9M -79.87M -31.02M -388M -31.37M -30.7M -1.35B	-29.05B -18.91M -16.48M -15.19M -14.29M -26.73M -1.78B -26.91M -181M -70.17M -878M -70.97M -69.45M -3.04B